dalteparin has been researched along with nitroglycerin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Nisio, M; Peinemann, F; Porreca, E; Rutjes, AW | 1 |
| Garner, O; Iardino, A; Lorusso, G; Lotta, F | 1 |
| Kohlert, S; McLean, L; Scarvelis, D; Thompson, C | 1 |
| Abittan, AI; Abittan, B; Lebwohl, M; Rivera-Oyola, R; Weingarten, M | 1 |
2 review(s) available for dalteparin and nitroglycerin
| Article | Year |
|---|---|
Treatment for superficial infusion thrombophlebitis of the upper extremity.
Topics: Anti-Inflammatory Agents; Anticoagulants; Catheterization, Peripheral; Dalteparin; Diclofenac; Drug Combinations; Drugs, Chinese Herbal; Escin; Gels; Heparin; Heparinoids; Humans; Ibuprofen; Nitroglycerin; Pentosan Sulfuric Polyester; Phospholipids; Polydeoxyribonucleotides; Randomized Controlled Trials as Topic; Thrombophlebitis; Upper Extremity | 2015 |
A case report of severe nasal ischemia from cold agglutinin disease and a novel treatment protocol including HBOT.
Topics: Administration, Topical; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Anticoagulants; Combined Modality Therapy; Enoxaparin; Female; Humans; Hyperbaric Oxygenation; Ischemia; Nitroglycerin; Nose; Ointments; Vasodilator Agents | 2019 |
2 other study(ies) available for dalteparin and nitroglycerin
| Article | Year |
|---|---|
Headache in an HIV-Positive Patient: Dangerous Interaction.
Topics: Adult; Anti-HIV Agents; Anticoagulants; Cilostazol; Cytochrome P-450 CYP3A Inhibitors; Dideoxynucleosides; Drug Combinations; Drug Interactions; Enoxaparin; Ergotamine; Ergotism; Headache; HIV Infections; Humans; Ischemia; Lamivudine; Lower Extremity; Male; Nitroglycerin; Ritonavir; Saquinavir; Tetrazoles; Tibial Arteries; Ultrasonography, Doppler, Color; Vasoconstrictor Agents; Vasodilator Agents | 2018 |
Treatment of COVID-19 induced chilblains with topical nitroglycerin.
Topics: Administration, Cutaneous; Anticoagulants; Betacoronavirus; Chilblains; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Enoxaparin; Fingers; Humans; Male; Middle Aged; Nitroglycerin; Ointments; Pandemics; Pneumonia, Viral; SARS-CoV-2; Skin; Treatment Outcome | 2020 |